HighQC™ Human IPSC From Corneal Epithelial Cells-Diabetes

Description

HighQC™ Human IPSC From Corneal Epithelial Cells-Diabetes is a disease-relevant human induced pluripotent stem cell line. It was generated by reprogramming primary corneal epithelial cells obtained from a donor with Diabetes Mellitus. The reprogramming was performed using non-integrating episomal plasmid method. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with well-defined borders and a high nucleus-to-cytoplasm ratio. These cells sustain pluripotency for diabetes-related cellular mechanism research. They retain the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. Core pluripotency marker SSEA-4 is expressed. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.